MV-NIS was shown to exhibit a profound synergy with the β- particle emitting radioiodine isotope 131I in a multiple myeloma xenograft model, wherein the administration of 37 MBq 131I at peak infection resulted in complete tumor regression in all the animals under study[14]. The gene discussed is SLC5A5; the disease is neoplasm.